Kymos Group

Executive Summary

Kymos Group, headquartered in Barcelona, Spain, is a European Contract Research Organization (CRO) specializing in bioanalytical and Chemistry, Manufacturing, and Controls (CMC) services. Founded in 2001, the company operates GLP- and GMP-certified laboratories across Europe, providing analytical support for small molecules, biologics, TIDES (oligonucleotides and peptides), and advanced therapies throughout the drug development lifecycle. Kymos has a strong regulatory track record, having been successfully inspected by major authorities including the FDA, EMA, and ANVISA. As a private, pre-clinical stage company, it is well-positioned to capitalize on the growing demand for specialized CRO services, particularly in the rapidly expanding TIDES and advanced therapy markets. The company's established infrastructure and regulatory compliance make it an attractive partner for pharmaceutical and biotech firms seeking high-quality analytical and CMC support. With a focus on innovation and quality, Kymos is expected to continue its growth trajectory by expanding its service offerings and geographic reach, leveraging its reputation for regulatory excellence to win new contracts and partnerships in the competitive European CRO landscape.

Upcoming Catalysts (preview)

• Q3 2026Announcement of new GMP-certified laboratory expansion for TIDES services70% success
• Q4 2026Major contract win with a top pharmaceutical company for bioanalytical support60% success
• Q1 2027Strategic acquisition of a complementary CRO in Northern Europe to expand geographic footprint50% success